FDA Drug Label · 2021

WEGOVY (semaglutide) injection, for subcutaneous use - Prescribing Information

Novo Nordisk (2021). WEGOVY (semaglutide) injection, for subcutaneous use - Prescribing Information. FDA Drug Label.

FDA Drug Label

View original source
XRedditFacebook

Peptides linked in PeptIQ Wiki

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.